Organisation paid for research Program year 2025 Source: CMS Open Payments

Clinical Trials Resource Group LLC

Neither a doctor nor a teaching hospital

Research payments

$5,427,336

100 payments

Through program year 2025, Clinical Trials Resource Group LLC is reported as receiving $5,427,336 in research payments, across 100 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $1,981,650 37
2024 Research $752,046 41
2023 Research $660,013 9
2022 Research $709,096 8
2021 Research $1,095,668 4
2020 Research $228,863 1

Breakdown

Who paid Research payments · program years 2020–2025
  1. Regeneron Pharmaceuticals, Inc. $5,427,336 100 payments
Studies the money was for Research payments · program years 2020–2025
  1. Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year Panorama Trial $2,733,696 78 payments
  2. Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial $2,693,640 22 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record